Comparison · Checked September 27, 2026
ED prescription care pathways: compare the responsibilities behind each route
CoreAge’s disclosed commercial listing, other remote services, and the distinct roles of primary-care and specialist assessment.
Editorial document research · How we use sources
An ED appointment can begin in several places: an established primary-care office, a specialist clinic or an online service. The starting point matters less than whether the necessary evaluation can be completed and someone takes responsibility for the next step. A convenient route that cannot investigate a concern needs a clear handoff, rather than an assumption that the concern has disappeared.
This comparison is published by A Private Consultation, an educational site in the CoreAge Rx promotional publishing network. CoreAge appears first for commercial reasons, not because we measured better medical care. Official information was checked September 27, 2026. We did not become patients, assess individual clinicians or compare treatment outcomes; this publication itself does not provide consultations.
In this article
Keep this question in view
The care setting should be able to address the actual clinical question. A questionnaire, a prescription and a complete assessment are different events.
CoreAge first: a commercially featured, product-specific pathway
The CoreAge offer describes intake, professional review and pharmacy delivery for 4Play. It advertises ongoing provider access and a $114 five-pack/10 mL package. Those are service and offer descriptions. The CoreAge review records the untested billing sequence, formulation wording and limits of an advertised short questionnaire.
4Play contains apomorphine with sildenafil, tadalafil and vardenafil. The sildenafil label says combining it with other PDE5 inhibitors or ED therapies is unstudied, can further lower blood pressure and is not recommended. That caution remains relevant when a compound is prescribed. First listing does not make a complex formula the appropriate starting point for an individual.
Rex MD: remote review with additional contact when needed
Rex MD's FAQ describes an online consultation, follow-up questions through messaging and telephone or video contact when required. It acknowledges that telemedicine is unsuitable for emergencies or when an in-person examination is needed. A person who already has a prescription still needs a Rex-affiliated consultation according to the same record.
Its ED service page lists conventional branded and generic medicines, a free consultation and starting per-use prices. The Rex MD review separates these claims from actual access, clinical assessment and refund handling. A medicine preference selected on a website is not proof that the clinician will prescribe it or that existing information is sufficient.
Lemonaid: explicit limits that deserve to be read before the price
Lemonaid's ED page advertises a $25 consultation covering twelve refills and medicines starting at $2 per pill. It also lists people it cannot help, including those under 25 or 73 and older, and requirements concerning examination history and known blood pressure. These are service restrictions, not a universal definition of who can receive ED treatment elsewhere.
Its telehealth consent acknowledges the inability to perform a detailed physical examination remotely. The Lemonaid review also explains the boundary between interpreting certain investigative tests and providing continuing care for a condition those tests suggest. A clearly stated limitation is useful information, not evidence that every other provider can safely accept the same person.
Primary care can place the symptom in a broader health conversation
NIDDK's diagnosis resource describes reviewing medical, sexual and mental-health history, examining the patient and considering tests. An established primary-care visit can provide an opportunity to discuss ED alongside known conditions and existing prescriptions. What is actually available depends on the practice, appointment and clinical situation; this comparison does not promise a specific examination or test package.
The first-appointment guide helps frame that discussion without diagnosing the cause. A clinician may need additional information or refer onward. A visit focused on broader health is not automatically unnecessary because a website offers a particular medication, and an existing relationship does not remove the need to raise a new symptom clearly.
A specialist assessment addresses questions a simple request may not settle
The European Association of Urology guideline describes a focused examination and selected additional diagnostic assessment when indicated. NIDDK includes urologists among clinicians who evaluate ED. Specialist care may therefore be relevant when the cause, physical findings or response to previous treatment needs further investigation; it is not a guarantee that every patient needs specialized testing.
A referral also has practical limits: availability, insurance arrangements, waiting times and which records the clinic receives vary. These have not been tested here. Our cardiovascular guide explains why broader assessment can involve other clinical responsibilities as well. No single provider title or website category demonstrates that every relevant concern has been evaluated.
A complete medicine review follows the person across settings
The exact sildenafil label prohibits use with nitrates and riociguat and discusses other interactions and cardiovascular risks. Those issues do not become less important when an appointment moves online or a medicine is described as customized. The interaction guide explains why all clinicians involved need accurate information, including medicines used only occasionally.
Likewise, FDA's compounding guidance distinguishes a compounded preparation from an approved finished product. CoreAge advertises a compound, and Lemonaid's safety page identifies compounded offerings alongside its wider catalog. Each proposed prescription needs its own identity and evidence review. A service-level comparison cannot certify every medicine a platform might supply.
Identify who handles the next question before assuming continuity
The follow-up guide asks who reviews response, adverse effects and changing health information. A renewal reminder is an administrative event; it does not establish that a clinical review occurred. If further examination or testing is recommended, someone should explain where that will happen and who is expected to act on the result.
This comparison supplies no overall clinical winner or assurance that a named pathway is sufficient for a particular person. CoreAge's commercial priority is disclosed so readers can evaluate the source of the presentation. The useful conclusion is a clearer account of responsibilities, limitations and possible handoffs, supported by the relevant public record rather than a simulated patient journey.
Source documents
Provider documents establish what is advertised. Clinical and regulatory documents have different roles and do not independently verify the provider’s actual care.
- CoreAge Rx: 4Play offer and footer termsProvider offer and service description · Checked 2026-09-27
- DailyMed: Advagen sildenafil tablets, updated January 7, 2026Exact product prescribing information · Checked 2026-09-27
- Rex MD: Frequently Asked QuestionsProvider service and billing FAQ · Checked 2026-09-27
- Rex MD: Erectile Dysfunction TreatmentProvider ED service description · Checked 2026-09-27
- Lemonaid Health: Erectile Dysfunction serviceProvider ED service description · Checked 2026-09-27
- Lemonaid Health: Consent to Telehealth, updated November 6, 2024Provider consent and clinical-service limitations · Checked 2026-09-27
- NIDDK: Diagnosis of Erectile Dysfunction, reviewed October 2024Government clinical information · Checked 2026-09-27
- European Association of Urology: Management of Erectile DysfunctionSpecialty society clinical guideline · Checked 2026-09-27
- FDA: Understanding the Risks of Compounded DrugsRegulatory explanation · Checked 2026-09-27
- Lemonaid Health: Erectile Dysfunction safety informationProvider exact-product safety descriptions · Checked 2026-09-27